<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30092969</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>01</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1876-7591</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>11</Volume>                    <Issue>8</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                    </PubDate>                </JournalIssue>                <Title>JACC. Cardiovascular imaging</Title>                <ISOAbbreviation>JACC Cardiovasc Imaging</ISOAbbreviation>            </Journal>            <ArticleTitle>Contemporary Role of Echocardiography for Clinical Decision Making in Patients During and After Cancer Therapy.</ArticleTitle>            <Pagination>                <MedlinePgn>1122-1131</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S1936-878X(18)30459-5</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcmg.2018.03.025</ELocationID>            <Abstract>                <AbstractText>Early recognition of cancer therapy-related cardiac dysfunction (CTRCD) provides an opportunity to mitigate cardiac injury and risk of developing late cardiac events. Echocardiography serves as the cornerstone in the detection and surveillance of CTRCD in patients during and after cancer therapy. Guidelines from professional societies and regulatory agencies have been published on approaches to surveillance, diagnosis, and treatment of CTRCD, although adoption as standard of care remains limited given the lack of evidence on the prognostic value of asymptomatic left ventricular (LV) dysfunction in the oncology population. The frequency of cardiac monitoring and the appropriateness of the Food and Drug Administration (FDA)-recommended cardiac monitoring schedule in all patients receiving trastuzumab for breast cancer has been challenged. Interruption versus continuation of oncological therapy in the setting of asymptomatic LV dysfunction remains a clinical conundrum given the uncertain balance of the risk of cardiac dysfunction and benefit of oncology efficacy. Despite their limitations, echocardiographic measures of LV function continue to play a pivotal role in clinical decision making, with global longitudinal strain emerging as a promising tool in informing and facilitating the selection of cancer treatment and optimizing cardiovascular outcomes. This review highlights the key recommendations of the existing guidelines and discusses recent developments in cardio-oncology imaging practices with the aim of providing practical guidance on the role and use of echocardiography in challenging clinical cases in cardio-oncology.</AbstractText>                <CopyrightInformation>Copyright Â© 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Liu</LastName>                    <ForeName>Jennifer</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Cardiology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, New York. Electronic address: liuj1234@mskcc.org.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Banchs</LastName>                    <ForeName>Jose</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mousavi</LastName>                    <ForeName>Negareh</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Cardiology, McGill University Health Center, Montreal, Quebec, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Plana</LastName>                    <ForeName>Juan Carlos</ForeName>                    <Initials>JC</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Cardiology, Texas Heart Institute Baylor St. Luke's Medical Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Scherrer-Crosbie</LastName>                    <ForeName>Marielle</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Cardiology, The Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Thavendiranathan</LastName>                    <ForeName>Paaladinesh</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Cardiology, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Barac</LastName>                    <ForeName>Ana</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, DC. Electronic address: ana.barac@medstar.net.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>JACC Cardiovasc Imaging</MedlineTA>            <NlmUniqueID>101467978</NlmUniqueID>            <ISSNLinking>1876-7591</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="ErratumIn">                <RefSource>JACC Cardiovasc Imaging. 2018 Oct;11(10):1556</RefSource>                <PMID Version="1">30286917</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">cardio-oncology</Keyword>            <Keyword MajorTopicYN="N">cardiotoxicity</Keyword>            <Keyword MajorTopicYN="N">echocardiography</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2017</Year>                <Month>11</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>02</Month>                <Day>14</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>03</Month>                <Day>08</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>11</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>11</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>11</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30092969</ArticleId>            <ArticleId IdType="pii">S1936-878X(18)30459-5</ArticleId>            <ArticleId IdType="doi">10.1016/j.jcmg.2018.03.025</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>